CDKN2A and diabetic kidney disease: Another clinical study in the same year suggested that after 11 days of DQ in patients with diabetic nephropathy, the expression of p16INK4A by senescent adipocytes was reduced and SASP levels (e.g., IL-6, IL-1α) were also decreased [146].